List your tool

Head to head · 2026

Bioptimus vs Paige

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Bioptimus

Foundation models for biology spanning molecular, cellular and tissue scales

4.2Not listed

Visit Bioptimus (opens Bioptimus in a new tab)

Paige

Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025

4.1Not listed

Visit Paige (opens Paige in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Bioptimus does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Bioptimus

    4.2 against 4.1

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onBioptimusPaige
Our rating4.2Better4.1
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Foundation models trained across molecular, cellular and tissue scales
  • Digital pathology models for research and trial workflows
  • Transfer learning that reuses existing imaging and omics archives
  • Benchmarked against independent public evaluations
  • Research, clinical trial and diagnostics use cases
  • Paige Alba AI co-pilot for digital pathology tissue-slide analysis
  • Cancer diagnosis, tissue subtyping, and molecular biomarker discovery support
  • Founded in 2017 by researchers from Memorial Sloan Kettering Cancer Center
  • Acquired by Tempus in August 2025, continuing under its own brand
  • Enterprise deployment with dedicated support for hospital and lab pathology teams
Pros
  • Cross-scale model design rather than one narrow task classifier
  • Extracts additional value from data a lab already holds
  • Published benchmark results give an external reference point
  • Research pedigree from Memorial Sloan Kettering lends real clinical credibility
  • Tempus backing adds financial resources and precision-medicine data integration
  • Deep oncology pathology specialization outperforms general-purpose medical imaging AI
Cons
  • Requires in-house validation on local cohorts before clinical reliance
  • Enterprise-only engagement with no self-serve access
  • Enterprise-only pricing requires a sales conversation before evaluation
  • Now part of a larger company, a real change from its independent-startup years
  • Narrow pathology focus means it's not a fit for non-oncology diagnostic workflows
CompanyBioptimus, founded 2024Paige, founded 2017

Prices come from each vendor's pricing page, last checked 20260812. Check the vendor before you buy.

FAQ

Questions people ask

Is Bioptimus better than Paige?

In our reviews Bioptimus scores 4.2 and Paige scores 4.1. The better pick depends on the job. Bioptimus: Foundation models for biology spanning molecular, cellular and tissue scales. Paige: Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025.

Which is cheaper, Bioptimus or Paige?

Bioptimus: see pricing. Paige: see pricing.

Do Bioptimus and Paige have free plans?

Neither lists a free plan.

More comparisons